CME Group (NASDAQ:CME) 주식

CME GROUP INC

CME Group

CME Gr

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Golden,Xrp,Coins,Are,Displayed,In,Front,Of,Green,And

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$XRP

파생상품 트레이더들은 목요일(24일) CME 그룹이 XRP 선물 상품을 공개하자 XRP(CRYPTO: XRP) 가격 상승에 공격적으로 베팅했다.

XRP, CME 그룹에서 선물 상품 공개···파생상품 시장에서 롱 베팅 급증

Japan.Flag.Stockmarket.Shutterstock

Global

General

AAPL

DELL

NVDA

연방준비제도(연준)가 기준 금리를 25bp(베이시스 포인트) 인하할지, 50bp 인하할지는 수요일 회의 전에 가장 큰 관심사이다. 하지만 대답해야 할 &#39;더 큰 질문&#39;이 있다고 그레이트 힐 캐피털(Great Hill Capital)의 토마스 헤이즈(Thomas Hayes)가 벤징가(Benzinga)에 말했다.

연준이 금리 인하에 나서는 동안, 한 헤지 펀드는 더 큰 촉매제인 일본 중앙은행에 주목

Tesla's Sky-High Surge

Equities

Previews

Tech

Trading Ideas

ABBV

AGYS

ASML

BJRI

CHKP

CHTR

CMCSA

DECK

GATX

GOOG

GOOGL

JNPR

NFLX

NXPI

ODFL

ORLY

SKYW

SPOT

TSLA

VRSN

S&amp;P 500 기업들 중 약 14%가 6월 분기 실적을 발표했으며, 더 넓은 지수를 구성하는 기업들의 혼합 실적 성장률은 여전히 ​​양호하다. 이번 주에는 기술 보고 시즌이 공식적으로 시작될 것이며, 이는 최근 주에 가파른 하락세를 보인 시장의 향방을 잠재적으로 결정할 수 있다.

테슬라, 알파벳, GM 및 포드가 이번 주 실적 발표 주도하며 상승세 유지 위해 고군분투

CME Group Inc

COMPUTER ENGNR&CONSLTNG by Computer Engineering & Consulting Ltd

Computer Engineering & Consulting Ltd

CHINA MEIDONG AUTO HLDGS by China Meidong Auto Hldgs

China MeiDong Auto Holdings Ltd

CM ENERGY TECH CO LTD by CM ENERGY TECH CO LTD

CM Energy Tech Co Ltd

CREO MED GROUP LTD by CREO MED GROUP LTD.

Creo Medical Group PLC

CoinMerge (BEP-20)

CMONEY INC by cMoney, Inc.

Ripple (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) is currently at $2.35, <a href="https://www.benzinga.com/money/how-to-buy-ripple-xrp">growing 0.14% in a day</a>. After a fall of over 10% last week, Ripple managed to give 10.50% returns in a month. The rise follows the highly anticipated listing of XRP futures on the CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) that saw more than $2.4 million in trading volume on the launch day.
The launch comes after CME Group's regulatory approval, backed by the Commodity Futures Trading Commission&#8217;s decision to classify XRP as a commodity instead of a security. The classification not only confirms the legitimacy of XRP in the eyes of U.S. regulators but also opens the door for other regulated financial products based on the token.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto?<a href="http://coinbase-consumer.sjv.io/m5ALXy"> Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
</ul>
The SEC has postponed review of several XRP spot ETF applications, such as Grayscale&#8217;s XRP Trust conversion, and proposals from 21Shares, Bitwise, Canary Funds, and WisdomTree Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>). XRP supporters have been disappointed by the postponement, as the uncertainty can affect short-term prices.
A Bloomberg analyst dispelled investor fears by clarifying that postponements are the norm and early approvals are rare. He implied that any actual progress from the SEC is more likely to occur in Q3 or Q4 of the year.
Judge Analisa Torres denied a request by Ripple and the SEC to ease the $125 million penalty imposed on Ripple in 2024. If the judge rejects a second motion, XRP could file a cross-appeal, which could increase legal tensions and make regulatory outcomes more difficult. Resolving the SEC vs. Ripple legal standoff could be key to unlocking XRP-spot ETF approvals in the U.S.
Ripple is trading above its 50-day, 100-day, and 200-day exponential moving averages (EMAs), indicating strong medium to long-term support. The MACD has also given a sell signal, and the RSI is moving downward, indicating weakening momentum.
If bears gain control, XRP can slide down to support levels at $2.26 and $2.04. A bounce can take it back to its recent high of $2.65. If the global cryptocurrency market reaches the value of $40 trillion and XRP maintains a 4.55% market share, XRP&#8217;s market cap can reach $1.82 trillion.
Ripple&#8217;s growing institutional traction, expanding global remittance network, and ongoing regulatory clarity efforts put XRP on the list of legacy altcoins with real utility and adoption potential. Ripple CEO, Brad Garlinghouse, released a statement supporting the CME futures launch.
The CME futures launch is a milestone showing the increasing institutional adoption of XRP. As the line between mainstream finance and crypto continues to blur, XRP is becoming a bridge asset, not only in cross-border payments but in financial infrastructure. If Ripple resolves its legal challenges and the SEC ramps up ETF approvals, XRP could be on an uptrend once more, bracing for much bigger gains in the years ahead.
More Opportunities:
<ul class="wp-block-list">
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

Ripple CME Futures Launch Sees $2.4M Volume Amid SEC ETF Delay, Legal Tensions Could Rise

Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) is currently trading at $168.8, down nearly 1% in the last 24 hours and over 5% in the past week. After <a href="https://www.benzinga.com/money/how-to-buy-solana">reaching the $180 level</a>, the token struggled to maintain momentum and is showing signs of bearish pressure. The price slump comes amid Solana's bearish pressure while the community waits for key developments like the Alpenglow Upgrade and Solana Spaces take shape.
Solana may soon undergo its most significant consensus update to date with the introduction of Alpenglow, a proposal put forward by a developer to improve the blockchain's throughput and reliability. The new model introduces a two-layered solution intended to enhance the network's speed.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto?<a href="http://coinbase-consumer.sjv.io/m5ALXy"> Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
</ul>
The upgrade announced on Monday by Anza, a Solana Labs spinout, will replace the Proof of History and Tower BTF systems with Votor and Rotor, leading to faster transaction processing. Alpenglow's Votor system can finalize blocks in one voting round if 80% of the stake is online, or two rounds if only 60% respond. Both modes operate simultaneously to ensure faster finalization.&nbsp;
Rotor reduces the number of hops data takes between nodes, helping maintain faster block times. No official launch date has been confirmed yet, but this upgrade could reshape Solana's trajectory.
Max Resnick, a lead economist at Anza, endorsed Solana during his keynote at Solana's Accelerate Conference, stating that it was never meant to compete with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), but with the New York Stock Exchange (NYSE), NASDAQ Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>), CME Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), and other centralized venues.&nbsp;
According to Resnick, the goal is to reach a round trip confirmation time of 159 milliseconds. The platform will be doing consensus on multiple blocks at the same time, eventually once every 20 milliseconds, to pop out a new block, or a set of blocks, from concurrent leaders.
Solana Spaces store in New York has reopened as a temporary pop-up with a new core team, fueled by memecoin funding. Season 2 of Solana Spaces aims to run pop-up stores for crypto merchandise during crypto conferences. The revival of the physical store stoked fans, along with the varied merchandise on sale from multiple Solana-based projects and NFT collections.
The technical indicators are sounding caution, with the Ichimoku Cloud indicating market indecision and a bearish tilt. The token's BBTrend is currently in the negative territory for the third consecutive day at -4.31, suggesting bearish pressure.
Solana's EMA indicators are nearing a potential death cross, wherein the short-term EMA moves above the long-term EMA, indicating a bearish signal. If this occurs, SOL could retest support at $170. A break below this may drag the price down to $153.99, with a deeper slide towards $141 if bearish momentum increases.
If Solana manages to reclaim the upward momentum, the first key resistance will be $176.77, a breakout above which could open the path to the next target at $184.88.
Despite major protocol changes looming, investor confidence in Solana is lagging, as caution dominates market sentiment.
More Opportunities:
<ul class="wp-block-list">
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

$ETH

$SOL

NDAQ

Solana Price Drops Below $170, AlpenGlow Upgrade And Solana Spaces Create Buzz

CME Group, the world's leading derivatives marketplace, today announced its new XRP futures are now available for trading. The first trade, a block, took place on Sunday, May 18, and was cleared by Hidden Road.
CME Group XRP futures are available in both a micro-sized (2,500 XRP) and a larger-sized contract (50,000 XRP), and are cash-settled to the CME CF XRP-Dollar Reference Rate, which serves as a once-a-day reference rate of the U.S. dollar price of XRP and is calculated daily at 4:00 p.m. London time.

CME Group's XRP Futures Are Now Available For Trading

On May 20, a recent SEC filing unveiled that Phyllis M Lockett, Director at CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) made an insider sell.
What Happened: Lockett opted to sell 1,060 shares of CME Group, according to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001156375/000115637525000128//Archives/edgar/data/1156375/000115637525000128/0001156375-25-000128-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The transaction's total worth stands at $294,552.
The latest market snapshot at Tuesday morning reveals CME Group shares up by 0.17%, trading at $278.4.
<h3>About CME Group</h3>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>CME Group's Financial Performance</h3>
Revenue Growth: Over the 3 months period, CME Group showcased positive performance, achieving a revenue growth rate of 10.38% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 87.41%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): CME Group's EPS outshines the industry average, indicating a strong bottom-line trend with a current EPS of 2.63.
</li>
</ul>
Debt Management: CME Group's debt-to-equity ratio is below the industry average. With a ratio of 0.13, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 27.96, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 15.92 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio of 19.74 trails industry averages, indicating a potential disparity in market valuation that could be advantageous for investors.
</li>
</ul>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions serve as a piece of the puzzle in investment decisions, rather than the entire picture.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Understanding Crucial Transaction Codes</h3>
When it comes to transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001156375">Check Out The Full List Of CME Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Insider Unloading: Phyllis M Lockett Sells $294K Worth Of CME Group Shares

Ripple (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) slipped by over 1.44% in the past 24 hours, <a href="https://www.benzinga.com/money/how-to-buy-ripple-xrp">trading at $2.34</a>. As traders brace for a week driven by the launch of CME futures, and BitMEX partnership speculations, the broader market has shown positive momentum. XRP has remained limited to a range between $2.32 and $2.62 over the past week.
The market focus is on the expected launch of XRP and Micro XRP futures on the Chicago Mercantile Exchange (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), scheduled to go live Monday, pending regulatory approval. Per the CME Group, these contracts will be cash-settled using the CME CF XRP-DOLLAR Reference Rate, with each standard contract representing 50,000 and 2,500 XRP.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto?<a href="http://coinbase-consumer.sjv.io/m5ALXy"> Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
</ul>
Traders are closely monitoring XRP's charts to determine if this development could inject new momentum into its current price trend, fueling a spark of optimism.
Adding to Coinpedia, crypto exchange BitMEX has hinted at a collaboration with Ripple. On May 17th, in a cryptic post on X that has garnered nearly half a million views, BitMex shared a GIF with the caption "news that's gonna have a @ripple effect on the market."&nbsp;
There are rumors that BitMEX is integrating XRP; however, no further details have been confirmed by either party.
During the Dubai Fintech Summit, Ripple underscored its commitment to the global digital asset space, where company president, Monica Long, met with Sheikh Ahmed bin Saeed Al Maktoum.&nbsp;
Ripple continues to trade under pressure as it struggles to reclaim bullish momentum after facing strong rejection near the $2.45 resistance zone. While the token has briefly rallied above the $2.35 level, mirroring upward moves in Bitcoin (BTC) and Ethereum (ETH), selling pressure quickly intensified. A short-term peak formed at $2.4495 before retreating below the $2.4 level, slipping past the 0% Fibonacci retracement of the upward move from $2.299 to $2.449.
Immediate resistance lies at $2.40, with a stronger cap at $2.45. A breakout above this level can clear a path to $2.50. If momentum continues, the next resistance levels will be at $2.60, followed by $2.65 and $2.68. XRP could also potentially climb toward $2.80, a key target for bullish traders.
Conversely, failure to clear the $2.45 resistance could fuel further losses. The first support level lies at $2.3350, with more significant backing around $2.32. A break below the $2.32 mark may accelerate selling pressure, dragging XRP down to $2.20, or as low as $2.12 if bearish pressure intensifies.
The hourly RSI has dropped below the neutral 50 level, indicating a loss of bullish momentum. Meanwhile, MACD is gaining traction in bearish territory.
More Opportunities:
<ul class="wp-block-list">
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

Ripple Declines Amid CME Futures Launch, New Exchange Partnership On Horizon

Making a noteworthy insider sell on May 19, Charles P Carey, Director at CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), is reported in the latest SEC filing.
What Happened: After conducting a thorough analysis, Carey sold 3,000 shares of CME Group. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001156375/000115637525000123//Archives/edgar/data/1156375/000115637525000123/0001156375-25-000123-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The total transaction value is $817,680.
CME Group shares are trading up 0.34% at $277.22 at the time of this writing on Monday morning.
<h3>Unveiling the Story Behind CME Group</h3>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>Financial Milestones: CME Group's Journey</h3>
Revenue Growth: CME Group displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 10.38%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Exploring Profitability:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 87.41%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): CME Group's EPS outshines the industry average, indicating a strong bottom-line trend with a current EPS of 2.63.
</li>
</ul>
Debt Management: CME Group's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.13.
Understanding Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: CME Group's P/E ratio of 27.8 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 15.83 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 19.63, CME Group presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Relevance of Insider Transactions</h3>
In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>A Closer Look at Important Transaction Codes</h3>
Navigating through the landscape of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, precisely detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001156375">Check Out The Full List Of CME Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CME Group Director Sold $817K In Company Stock

CME Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CME#NYSE">CME</a>) short percent of float has fallen 12.66% since its last report. The company recently reported that it has 4.96 million shares sold short, which is 1.38% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.34 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>CME Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746720029_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CME Group has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing CME Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, CME Group's peer group average for short interest as a percentage of float is 3.72%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into CME Group's Recent Short Interest

High-rolling investors have positioned themselves bullish on CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in CME often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 9 options trades for CME Group. This is not a typical pattern.
The sentiment among these major traders is split, with 44% bullish and 44% bearish. Among all the options we identified, there was one put, amounting to $298,500, and 8 calls, totaling $1,021,803.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $260.0 and $290.0 for CME Group, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for CME Group's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CME Group's whale trades within a strike price range from $260.0 to $290.0 in the last 30 days. 
<h3>CME Group Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746640998_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$44.1</td>
<td>$40.7</td>
<td>$42.2</td>
<td>$270.00</td>
<td>$422.0K</td>
<td align="right">95</td>
<td align="right">100</td>
</tr>
<tr>
<td>CME</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$21.5</td>
<td>$19.5</td>
<td>$19.9</td>
<td>$270.00</td>
<td>$298.5K</td>
<td align="right">66</td>
<td align="right">150</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$17.4</td>
<td>$17.3</td>
<td>$17.4</td>
<td>$290.00</td>
<td>$193.1K</td>
<td align="right">261</td>
<td align="right">289</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$25.9</td>
<td>$25.0</td>
<td>$25.0</td>
<td>$260.00</td>
<td>$100.0K</td>
<td align="right">619</td>
<td align="right">41</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$18.4</td>
<td>$17.6</td>
<td>$17.6</td>
<td>$290.00</td>
<td>$98.5K</td>
<td align="right">261</td>
<td align="right">700</td>
</tr>
</tbody>
</table>

<h3>About CME Group</h3>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Having examined the options trading patterns of CME Group, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is CME Group Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 550,783, with CME's price up by 0.71%, positioned at $284.99.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 77 days.</li>
</ul>
<h3>What The Experts Say On CME Group</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $277.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for CME Group, targeting a price of $305. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on CME Group with a target price of $304. 
&#x2A; An analyst from Piper Sandler persists with their Overweight rating on CME Group, maintaining a target price of $283. 
&#x2A; An analyst from JP Morgan has decided to maintain their Underweight rating on CME Group, which currently sits at a price target of $211. 
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on CME Group, maintaining a target price of $283. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for CME Group with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

CME Group's Options: A Look at What the Big Money is Thinking

CME Group Hits Record 35.9M Daily Contracts in April, Driven by Interest Rates, Equities, Metals, And Global Demand

Dennis Suskind, Director at CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), executed a substantial insider sell on April 30, according to an SEC filing.
What Happened: Suskind's decision to sell 1,000 shares of CME Group was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001156375/000115637525000107//Archives/edgar/data/1156375/000115637525000107/0001156375-25-000107-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday. The total value of the sale is $271,280.
During Thursday's morning session, CME Group shares down by 0.34%, currently priced at $276.14.
<h3>About CME Group</h3>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>A Deep Dive into CME Group's Financials</h3>
Revenue Growth: Over the 3 months period, CME Group showcased positive performance, achieving a revenue growth rate of 7.67% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 87.41%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 2.63, CME Group showcases strong earnings per share.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.13.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 27.88 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 15.87 is above industry norms, reflecting an elevated valuation for CME Group's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): CME Group's EV/EBITDA ratio, lower than industry averages at 19.68, indicates attractively priced shares.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
Insider transactions serve as a piece of the puzzle in investment decisions, rather than the entire picture.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Unlocking the Meaning of Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001156375">Check Out The Full List Of CME Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Decision: Dennis Suskind Offloads $271K Worth Of CME Group Stock

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/04/30/final-trades-berkshire-hathaway-vertex-pharma-sp-global-and-cme-group.html">Halftime Report Final Trades</a>,&#8221; Jim Lebenthal of Cerity Partners named Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) as his final trade ahead of its quarterly <a href="https://www.benzinga.com/quote/BRK.B/analyst-ratings">earnings report on Saturday</a>.
On April 25, UBS analyst Brian Meredith maintained a Buy rating for Berkshire Hathaway and raised the price target from $557 to $606.
Stephen L. Weiss of Short Hills Capital Partners picked Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) as his final trade.
Lending support to his choice, Cantor Fitzgerald analyst Carter Gould, on April 22, initiated coverage of Vertex Pharmaceuticals with an Overweight rating and announced a price target of $535.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Karen Firestone of Aureus Asset Management said S&amp;P Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) reported a great quarter.
S&amp;P Global reported quarterly adjusted earnings per share of $4.37 on Tuesday, beating the analyst consensus estimate of $4.19 per share. Quarterly sales of $3.78 billion (up 8% year over year) outpaced the street view of $3.70 billion. Revenue from subscription products increased 7%.
Joseph M. Terranova of Virtus Investment Partners said he likes CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>).
On the earnings front, CME Group posted first-quarter adjusted earnings of $2.80 per share on April 23, beating market estimates of $2.79 per share. The company's quarterly sales came in at $1.60 billion versus expectations of $1.64 billion.
Price Action:
<ul>
<li>Berkshire Hathaway shares fell 0.3% to close at $533.25 on Wednesday.</li>
<li>Vertex Pharmaceuticals gained 1.2% to close at $509.50 during Wednesday's session.</li>
<li>S&amp;P Global gained 1.7% to close at $500.05 on Wednesday.</li>
<li>CME Group shares climbed 1.7% to settle at $277.08 during the session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/45098110/top-2-materials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Materials Stocks That May Fall Off A Cliff This Quarter</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Media

SPGI

VRTX

S&P Global, Berkshire Hathaway, CME Group And A Health Care Stock: CNBC's 'Final Trades'

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/02/25</td>
<td>$60.00</td>
<td>$84.8K</td>
<td>15.2K</td>
<td>11.7K</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$290.00</td>
<td>$309.7K</td>
<td>147</td>
<td>486</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/02/25</td>
<td>$242.50</td>
<td>$25.4K</td>
<td>1.0K</td>
<td>438</td>
</tr>
<tr>
<td>V</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$340.00</td>
<td>$37.9K</td>
<td>48</td>
<td>373</td>
</tr>
<tr>
<td>NU</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$12.00</td>
<td>$29.0K</td>
<td>98.3K</td>
<td>340</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$115.00</td>
<td>$29.1K</td>
<td>3.4K</td>
<td>126</td>
</tr>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$60.00</td>
<td>$162.9K</td>
<td>9.5K</td>
<td>11</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we notice a call option sweep that happens to be bearish, expiring in 2 day(s) on May 2, 2025. This event was a transfer of 3787 contract(s) at a $60.00 strike. This particular call needed to be split into 52 different trades to become filled. The total cost received by the writing party (or parties) was $84.8K, with a price of $22.0 per contract. There were 15275 open contracts at this strike prior to today, and today 11789 contract(s) were bought and sold. 
• Regarding CME (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), we observe a call option sweep with bullish sentiment. It expires in 107 day(s) on August 15, 2025. Parties traded 484 contract(s) at a $290.00 strike. This particular call needed to be split into 36 different trades to become filled. The total cost received by the writing party (or parties) was $309.7K, with a price of $640.0 per contract. There were 147 open contracts at this strike prior to today, and today 486 contract(s) were bought and sold. 
• For JPM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), we notice a call option trade that happens to be bearish, expiring in 2 day(s) on May 2, 2025. This event was a transfer of 100 contract(s) at a $242.50 strike. The total cost received by the writing party (or parties) was $25.4K, with a price of $254.0 per contract. There were 1032 open contracts at this strike prior to today, and today 438 contract(s) were bought and sold. 
• For V (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), we notice a put option trade that happens to be bullish, expiring in 79 day(s) on July 18, 2025. This event was a transfer of 29 contract(s) at a $340.00 strike. The total cost received by the writing party (or parties) was $37.9K, with a price of $1310.0 per contract. There were 48 open contracts at this strike prior to today, and today 373 contract(s) were bought and sold. 
• For NU (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>), we notice a call option trade that happens to be neutral, expiring in 261 day(s) on January 16, 2026. This event was a transfer of 131 contract(s) at a $12.00 strike. The total cost received by the writing party (or parties) was $29.0K, with a price of $222.0 per contract. There were 98322 open contracts at this strike prior to today, and today 340 contract(s) were bought and sold. 
• Regarding MS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), we observe a put option sweep with bearish sentiment. It expires in 51 day(s) on June 20, 2025. Parties traded 53 contract(s) at a $115.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $29.1K, with a price of $550.0 per contract. There were 3480 open contracts at this strike prior to today, and today 126 contract(s) were bought and sold. 
• Regarding PYPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), we observe a call option trade with bearish sentiment. It expires in 16 day(s) on May 16, 2025. Parties traded 300 contract(s) at a $60.00 strike. The total cost received by the writing party (or parties) was $162.9K, with a price of $543.0 per contract. There were 9514 open contracts at this strike prior to today, and today 11 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HOOD

PYPL

7 Financials Stocks With Whale Alerts In Today's Session

Analyst Ratings

BRK/B

CNBC Halftime Report Final Trades: Berkshire Hathaway - B Shares, Vertex Pharmaceuticals, S&P Global, CME Group

On April 28, a recent SEC filing unveiled that Larry G Gerdes, Board Member at CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) made an insider sell.
What Happened: Gerdes's decision to sell 4,000 shares of CME Group was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001156375/000115637525000100//Archives/edgar/data/1156375/000115637525000100/0001156375-25-000100-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The total value of the sale is $1,060,441.
During Tuesday's morning session, CME Group shares up by 0.27%, currently priced at $268.63.
<h3>Unveiling the Story Behind CME Group</h3>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>Financial Insights: CME Group</h3>
Revenue Growth: CME Group displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 7.67%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Interpreting Earnings Metrics:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 87.41%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): CME Group's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 2.63.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.13, CME Group adopts a prudent financial strategy, indicating a balanced approach to debt management.
Evaluating Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 26.95 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 15.35 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): CME Group's EV/EBITDA ratio, lower than industry averages at 19.05, indicates attractively priced shares.
</li>
</ul>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Understanding Crucial Transaction Codes</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001156375">Check Out The Full List Of CME Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Larry G Gerdes Executes Sell Order: Offloads $1.06M In CME Group Stock

CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) has been analyzed by 17 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">8</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for CME Group, revealing an average target of $266.18, a high estimate of $305.00, and a low estimate of $211.00. Witnessing a positive shift, the current average has risen by 3.75% from the previous average price target of $256.56.
<img src="https://www.benzinga.com/files/images/story/2025/1745618427_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive CME Group. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;---------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Alex Kramm &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $305.00&#x7C;$290.00 &#x7C; 
&#x7C;Mike Cyprys &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $304.00&#x7C;$301.00 &#x7C; 
&#x7C;Kyle Voigt &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Market Perform &#x7C; $273.00&#x7C;$265.00 &#x7C; 
&#x7C;Kenneth Worthington &#x7C;JP Morgan &#x7C;Lowers &#x7C;Underweight &#x7C; $211.00&#x7C;$223.00 &#x7C; 
&#x7C;Benjamin Budish &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $283.00&#x7C;$279.00 &#x7C; 
&#x7C;Owen Lau &#x7C;Oppenheimer &#x7C;Raises &#x7C;Outperform &#x7C; $279.00&#x7C;$269.00 &#x7C; 
&#x7C;Patrick Moley &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $283.00&#x7C;$275.00 &#x7C; 
&#x7C;Benjamin Budish &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $279.00&#x7C;$263.00 &#x7C; 
&#x7C;Ashish Sabadra &#x7C;RBC Capital &#x7C;Maintains &#x7C;Sector Perform &#x7C; $269.00&#x7C;$269.00 &#x7C; 
&#x7C;Craig Siegenthaler &#x7C;B of A Securities &#x7C;Raises &#x7C;Underperform &#x7C; $219.00&#x7C;$200.00 &#x7C; 
&#x7C;Patrick O'Shaughnessy&#x7C;Raymond James &#x7C;Announces &#x7C;Outperform &#x7C; $287.00&#x7C;- &#x7C; 
&#x7C;Mike Cyprys &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Equal-Weight &#x7C; $263.00&#x7C;$256.00 &#x7C; 
&#x7C;Kyle Voigt &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Market Perform &#x7C; $257.00&#x7C;$256.00 &#x7C; 
&#x7C;Ashish Sabadra &#x7C;RBC Capital &#x7C;Raises &#x7C;Sector Perform &#x7C; $269.00&#x7C;$235.00 &#x7C; 
&#x7C;Owen Lau &#x7C;Oppenheimer &#x7C;Raises &#x7C;Outperform &#x7C; $269.00&#x7C;$258.00 &#x7C; 
&#x7C;Kenneth Worthington &#x7C;JP Morgan &#x7C;Raises &#x7C;Underweight &#x7C; $212.00&#x7C;$209.00 &#x7C; 
&#x7C;Benjamin Budish &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $263.00&#x7C;$257.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to CME Group. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of CME Group compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of CME Group's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CME/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CME Group analyst ratings.</a>
<h2>About CME Group</h2>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
<h3>CME Group: Financial Performance Dissected</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: CME Group displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 7.67%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: CME Group's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 57.49%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.53%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): CME Group's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.64%, the company may face hurdles in achieving optimal financial performance.
Debt Management: CME Group's debt-to-equity ratio is below the industry average. With a ratio of 0.13, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into CME Group Stock: Analyst Perspectives (17 Ratings)

UBS analyst Alex Kramm maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Buy and raises the price target from $290 to $305.

Price Target

UBS Maintains Buy on CME Group, Raises Price Target to $305

Derivatives traders aggressively bet on XRP's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) price increase amid the announcement of the coin's futures contracts on CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) on Thursday.
What happened: More than 70.73% of traders on Binance with an open XRP position were positioned long, up from 67.57% a week ago, <a href="https://www.coinglass.com/LongShortRatio">according</a> to Coinglass.
It indicated that the number of individuals holding long positions in XRP was 2.42 times higher than those holding short positions.
Bullish expectations were also high among the top 20% of traders with the highest margin balance, with approximately 69.43% betting on XRP&#8217;s rally.
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/25/04/44971891/sec-teams-up-with-nayib-bukele-led-el-salvador-for-a-crypto-regulatory-sandbox">SEC Zooms In On Nayib Bukele-Led El Salvador&#8217;s Crypto Regulation Model</a>
The Open Interest in XRP futures fell 1.74% in the last 24 hours but was up nearly 23% over the week, signaling a jump in leverage and speculative demand.
Why It Matters: The move comes as leading derivatives marketplace CME Group <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44984259/cme-group-to-launch-xrp-futures-in-may-how-did-xrp-price-react">announced an XRP futures offering</a>, allowing investors to profit from the coin&#8217;s volatility without directly holding it.
Traders will have access to two contract sizes: a micro contract (2,500 XRP) and a standard contract (50,000 XRP), and they will be cash-settled.
The buzz around investment vehicles seeking exposure to XRP, the fourth-largest cryptocurrency, has soared since Ripple Labs and the SEC <a href="https://www.benzinga.com/top-stories/25/04/44758705/ripple-sec-move-to-end-legal-dispute-as-both-sides-withdraw-appeals">agreed to a final resolution</a> of their lengthy legal feud.
As of this writing, the odds of an XRP exchange-traded fund approval in 2025 were 71% on Polymarket. Investment giants like Grayscale Investments, Franklin Templeton, and WisdomTree have <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43720517/xrp-outshines-bitcoin-ethereum-after-sec-acknowledges-grayscale-etf-filing">filed applications</a> with the SEC to launch XRP ETFs.
Price Action: At the time of writing, XRP was exchanging hands at $2.17, down 1.15% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Shares of CME Group rose 1.17% in after-hours trading after closing 0.68% higher at $263.27 during Thursday&#8217;s regular session. 
As of this writing, the CME stock has a high momentum score but a lower valuation. To check how your favorite stocks fare on these parameters, click on <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a>. 
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="486" height="135" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24232903/Screenshot-2025-04-25-085848.png" alt="" class="wp-image-887833" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24232903/Screenshot-2025-04-25-085848.png 486w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24232903/Screenshot-2025-04-25-085848-300x83.png 300w" sizes="(max-width: 486px) 100vw, 486px" /></figure>
Photo: alfernec/shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44971214/solana-staking-etf-surges-18-in-debut-week-heres-how-much-cathie-woods-ark-invest-has-parked-in-it">Solana Staking ETF Surges 18% In Debut Week—Here&#8217;s How Much Cathie Wood&#8217;s Ark Invest Has Parked In It</a></li>
</ul>

XRP Bullish Bets In Derivatives Market Surge As CME Group Announces Futures Offering

Morgan Stanley analyst Mike Cyprys maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Overweight and raises the price target from $301 to $304.

Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $304

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Market Perform and raises the price target from $265 to $273.

Keefe, Bruyette & Woods Maintains Market Perform on CME Group, Raises Price Target to $273

JP Morgan analyst Kenneth Worthington maintains CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Underweight and lowers the price target from $223 to $211.

JP Morgan Maintains Underweight on CME Group, Lowers Price Target to $211

Press Releases

Sterling Trading Tech Names Julie Armstrong Chief Commercial Officer

Earnings

CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2025

CME Clearing Appoints New Chief Risk Officer

Fintech

CME Group to Expand Crypto Derivatives Suite with Launch of XRP Futures

CME Group Sets New ADV Record of 35.9 Million Contracts In April, Up 36% Year Over Year

Farmer sentiment improves as long-term optimism outweighs tariff concerns

Dividends

CME Group Declares Quarterly Dividend

CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting of Shareholders

CME Group Announces First Trades of XRP Futures

FX Spot+ Trades $1.4 Billion in a Single Day With Over 40 Clients Active in First Month

AGM Group Holdings Inc. - Class A Ordinary Shares

AGM Group Holdings

Aether Holdings

Bakkt Holdings, Inc. Class A Common Stock

Bakkt Hldgs

Coincheck Group

Coinbase Global, Inc. - Class A Common Stock

Coinbase Global

Donnelley Financial Solutions, Inc. Common Stock

Donnelley Financial Solns

FactSet Research Systems Inc. Common Stock

FactSet Research Systems

Intercontinental Exchange Inc. Common Stock

Intercontinental Exchange

Open Lending

Moodys

Marketwise

MarketAxess Holdings, Inc. - Common Stock

MarketAxess Holdings

Morningstar

MSCI

Nasdaq

Powell Max Limited - Class A Ordinary Shares

Powell Max

S&P Global

Tradeweb Markets Inc. - Class A Common Stock

Comments

CME Group

뉴스

파트너 / 기고자

벤징가 글로벌